Modified rice bran beneficial for weight loss of mice as a major and acute adverse effect of cisplatin

Pharmacology and Toxicology

Volumn 92, Issue 6, 2003, Pages 300-303

  Endo, Yuzo ^a   Kanbayashi, Hiroshi ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOXYLAN; CISPLATIN; HEMICELLULOSE; MGN 3; POLYSACCHARIDE; VEGETABLE PROTEIN;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; ARTIFICIAL DIET; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RICE BRAN; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; CISPLATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFUSIONS, PARENTERAL; MICE; MICE, INBRED BALB C; ORYZA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS; WEIGHT LOSS;

ANIMALIA;

EID: 0038071472     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920608.x     Document Type: Article

References (15)

1. Borchers, A. T., J. S. Stern, R. M. Hackman, C. L. Keen & M. E. Gershwin: Minireview. Mushrooms, tumors, and immunity. Pro. Soc. Exp. Biol. Med. 1999, 221, 281-293.
2. Ghoneum, M.: Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MNG-3). Int. J. Immunotherapy 1998, 14, 89-99.
3. Harrap, K. R.: Initiatives with platinum-and quinazoline-based antitumor molecules. Fourteenth Bruce F Cain Memorial Award Lecture. Cancer Res. 1995, 55, 2761-2768.
4. Jacoby H. I., G. Wnorowski, K. Sakata & H. Maeda: The effect of MGN-3 on cisplatin and adriamycin induced toxicity in the rat. Gastroenterol. 2000, 118 Suppl 2 (Part 2 of 2), A1069 (Abstract).
5. Kim, K. M., K. W. Yu, D. H. Kang, J. H. Koh, B. S. Hong & H. J. Suh: Anti-stress and anti-fatigue effects of fermented rice bran. Biosci. Biotechnol. Biochem. 2001, 65, 2294-2296.
6. Lajer, H. & G. Daugaard: Cisplatin and hypomagnesemia. Cancer Treat. Rev. 1999, 25, 47-58.
7. Loehrer, P. J. & L. H. Einhorn: Cisplatin, diagnosis and treatment. Ann. Intern. Med. 1984, 100, 704-713.
8. Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall: Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193, 267-275.
9. Ohara, I., R. Tabuchi & K. Onai: Effects of modified rice bran on serum lipids and taste preference in streptozotocin-induced diabetic rats. Nutr. Res. 2000, 20, 59-68.
10. Prestayko, A. W., C. D'Aoust, B. F. Issels & S. T. Crooke: Cisplatin (cis-diamminedichloro-platinum(II)). Cancer Treat. Rev. 1979, 6, 17-39.
11. Rosenberg, B., L. VanCamp, J. E. Tosko & V. H. Mansour: Platinum compounds: a new class of potent antitumor agents. Nature 1969, 222, 383-386.
12. Smith, I. E. & D. C. Talbot: Cisplatin and its analogs in the treatment of advanced breast cancer: a review. Brit. J. Cancer 1992, 65, 787-793.
13. Takenaka, S. & Y. Itoyama: Rice bran hemicellulose increases the peripheral blood lymphocytes in rats. Life Sci. 1993, 52, 9-12.
14. Takeo, S., H. Kado, H. Yamamoto, M. Kamimura, N. Watanabe, K. Uchida & Y. Mori: Studies on an antitumor polysaccharide RBS derived from rice bran. II. Preparation and general properties of RON, an active fraction of RBS. Chem. Pharm. Bull. 1988, 36, 3609-3613.
15. Zielen, S., M. Broeker, N. Strnad, L. Schwene, P. Schoen, G. Gottwald & D. Hofmann: Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J. Immunol. Meth. 1996, 193, 1-7.